Artesunate, a common herbal-based anti-malarial drug, can be used to control asthma, with better treatment outcomes than other drugs currently available, according to a paper by researchers from the National University of Singapore (NUS).
The authors write that artesunate is able to suppress airway inflammation and produce an array of anti-inflammatory effects similar to those by dexamethasone, the most potent steroid currently available, and with less side effects.
Asthma is an incurable lung disease that inflames and narrows the airways, causing recurring periods of wheezing, chest tightness, coughing and shortness of breath. It is a chronic condition that affects people of all ages, but it most often starts during childhood.
To address the global unmet demand for better therapeutics to control allergic asthma, Associate Professor Fred Wong from the Department of Pharmacology and Dr. Eugene Ho Wanxing explored the therapeutic values of artesunate, which is herbal-based, as an alternative drug candidate. This study was part of Dr Ho’s final-year project when he was pursuing a Bachelor of Science in Life Sciences at NUS. His initial findings demonstrated that artesunate possessed promising anti-inflammatory potential.
Dr Ho was recognised by the Singapore-MIT Alliance (SMA) in 2010 for his novel discovery, and he was awarded the SMA Graduate Fellowship for his PhD studies at NUS.
For his postgraduate studies, Dr Ho built upon his findings to better understand the therapeutic properties and molecular mechanisms of artesunate under the supervision of Assoc Prof Fred Wong.
The NUS team studied the therapeutic effects of artesunate against oxidative stress and oxidative lung damage which are major inflammatory events that contribute to the severity of asthma attacks. They found that artesunate could better prevent oxidative lung damage, a major molecular inflammatory event in asthmatic lungs, than clinically-used corticosteroid, dexamethasone.
Their collective results revealed that artesunate can be used to better control asthma, with improved outcomes and lesser adverse effects than currently available drugs. As long term usage of steroids may induce many potential side effects in asthmatic patients, the significance of this study suggests that the patients may eventually be able to adopt artesunate as a safer and more effective alternative to control their asthma.
Moving forward, the team led by Assoc Prof Wong will further explore the therapeutic and pharmacological effects of artesunate for asthma, as well as for other medical conditions. They also intend to work with industry partners to test the effects of artesunate on asthmatic patients.
Dr Ho is also furthering his research as a Research Fellow at the Saw Swee Hock School of Public Health at NUS, where he is investigating the molecular mechanisms of artesunate, and hopes to discover more beneficial effects of artesunate and accelerate the adoption of this drug for clinical tests.
Anti-malarial drug artesunate restores metabolic changes in experimental allergic asthma
Metabolomics (2014): 1-11 , July 16, 2014
Artemisinins: Pharmacological actions beyond anti-malarial
Pharmacology&Therapeutics, Volume 142, Issue 1, April 2014, Pages 126–139
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- Robot Tongue Identifies The Correct Beer Every Time
- Mystery Of Morgellons - Disease Or Delusion - Scientific Hypothesis Of Connection With Lyme Disease
- Satellites Catch Birth Of Two Volcanic Islands In Yemen
- Illegal Immigration To The U.S. Caused By Globalization?
- Brain-Computer Interface Makes Communication For Kids With Cerebral Palsy Easier
- Editorial Independence Or Extortion? Frontiers Sacks 31 Editors
- Wealthy Elites Will Soon Get GMO-Free Similac
- "Okay, they can take Yellow dye #6 out of the nacho cheese, but don't touch mah Cheesy Puffs!..."
- "Jesus H Christ, you have not written a Wikipedia article, you've written the book! I personally..."
- "Thanks, Hank, for taking the time to write your commentary on the issue involving a number of our..."
- "Just found a post by Jester with some more detail on timetables for the rest of the year: http..."
- "Quick q: what's the expected timeline for reaching 1 fb^-1? (I'd be happy with a pointer where..."